Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02562027 · ClinicalTrials.gov registry record · NA
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
NCT02562027 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 217 participants.
The verdict
NCT02562027, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
Study Summary
A principle objective of the study is to create a validated risk model for treatment selection. This will greatly enhance the ability to counsel patients regarding their specific risks/benefit ratio for surgery or SBRT. This will improve informed decision making on the part of the patient, and remove much of the subjectivity of treatment selection.
Interventions
- BEHAVIORAL European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30
- BEHAVIORAL European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13
- BEHAVIORAL Modified Medical Research Council
- BEHAVIORAL EQ-5D
- BEHAVIORAL Center for Epidemiological Studies Depression Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2015-09-11 |
| Est. Completion | 2020-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02562027
The ClinicalTrials.gov registry entry for NCT02562027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 is the first listed.
NCT02562027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02562027 about?
NCT02562027 is a clinical study titled "SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer". A principle objective of the study is to create a validated risk model for treatment selection. This will greatly enhance the ability to counsel patients regarding their specific risks/benefit ratio for surgery or SBRT. This will improve informed decision making on the part of the patient, and remov...
What is the current status of trial NCT02562027?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2015-09-11. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT02562027?
The interventions under investigation include: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (BEHAVIORAL), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13 (BEHAVIORAL), Modified Medical Research Council (BEHAVIORAL), EQ-5D (BEHAVIORAL), Center for Epidemiological Studies Depression Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT02562027?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.